A detailed history of Group One Trading, L.P. transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 900,144 shares of PACB stock, worth $2.21 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
900,144
Previous 193,915 364.2%
Holding current value
$2.21 Million
Previous $727,000 69.6%
% of portfolio
0.04%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.36 - $3.65 $960,471 - $2.58 Million
706,229 Added 364.2%
900,144 $1.23 Million
Q1 2024

May 10, 2024

SELL
$3.52 - $9.59 $739,453 - $2.01 Million
-210,072 Reduced 52.0%
193,915 $727,000
Q4 2023

Feb 14, 2024

BUY
$5.97 - $10.36 $730,292 - $1.27 Million
122,327 Added 43.43%
403,987 $3.96 Million
Q3 2023

Nov 09, 2023

BUY
$8.23 - $13.93 $355,684 - $602,026
43,218 Added 18.13%
281,660 $2.35 Million
Q2 2023

Aug 09, 2023

SELL
$9.97 - $14.05 $80,338 - $113,214
-8,058 Reduced 3.27%
238,442 $3.17 Million
Q1 2023

May 12, 2023

BUY
$7.94 - $12.02 $118,703 - $179,699
14,950 Added 6.46%
246,500 $2.85 Million
Q4 2022

Feb 09, 2023

BUY
$5.67 - $11.2 $1.31 Million - $2.59 Million
231,550 New
231,550 $1.89 Million
Q1 2021

May 12, 2021

SELL
$26.38 - $51.15 $7.49 Million - $14.5 Million
-283,842 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$10.5 - $28.5 $2.83 Million - $7.67 Million
269,134 Added 1829.85%
283,842 $7.36 Million
Q3 2020

Nov 12, 2020

SELL
$3.61 - $9.87 $56,973 - $155,768
-15,782 Reduced 51.76%
14,708 $145,000
Q2 2020

Aug 13, 2020

SELL
$2.65 - $4.03 $491,037 - $746,746
-185,297 Reduced 85.87%
30,490 $105,000
Q1 2020

May 13, 2020

BUY
$2.36 - $5.26 $362,033 - $806,905
153,404 Added 245.91%
215,787 $660,000
Q4 2019

Feb 10, 2020

SELL
$4.6 - $5.57 $96,245 - $116,541
-20,923 Reduced 25.12%
62,383 $321,000
Q3 2019

Nov 12, 2019

BUY
$4.99 - $6.16 $415,696 - $513,164
83,306 New
83,306 $430,000
Q2 2019

Aug 09, 2019

SELL
$5.92 - $7.41 $234,017 - $292,917
-39,530 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$6.8 - $7.4 $168,116 - $182,950
-24,723 Reduced 38.48%
39,530 $286,000
Q4 2018

Feb 06, 2019

BUY
$3.99 - $7.82 $159,520 - $312,643
39,980 Added 164.71%
64,253 $475,000
Q3 2018

Nov 08, 2018

SELL
$3.52 - $5.55 $167,604 - $264,263
-47,615 Reduced 66.23%
24,273 $131,000
Q2 2018

Aug 14, 2018

SELL
$2.11 - $3.92 $122,591 - $227,752
-58,100 Reduced 44.7%
71,888 $255,000
Q1 2018

May 11, 2018

SELL
$2.05 - $3.23 $154,465 - $243,377
-75,349 Reduced 36.7%
129,988 $266,000
Q4 2017

Feb 09, 2018

BUY
$2.59 - $5.44 $302,947 - $636,305
116,968 Added 132.36%
205,337 $542,000
Q3 2017

Nov 15, 2017

BUY
$3.2 - $5.57 $163,936 - $285,351
51,230 Added 137.94%
88,369 $464,000
Q2 2017

Aug 14, 2017

BUY
N/A
37,139
37,139 $132,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $553M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.